CLINICAL, SUBCLINICAL FEATURES AND RESULTS OF TREATMENT OF CYTOMEGALOVIRUS HEPATITIS IN CHILDREN

Thi Lan Ho1, Pham Anh Hoa Nguyen2, Manh Hung Vo1
1 Nghe An Obstetrics and Pediatrics Hospital
2 Vietnam National Children’s Hospital

##plugins.themes.vojs.article.main##

Abstract

Objective: To describe the clinical and subclinical characteristics of hepatitis in children due to viral cytomegalo-infection and to comment on the results of treatment of hepatitis in children due to viral cytomegalo-infection at the National Children’s Hospital.


Research object and method: Retrospective - prospective study,describing 89 pediatric patients 1-12 months diagnosed with Cytomegalovirus hepatitis and treated at the National Children’s Hospital during the period from 01/01/2020 - 30/06/2022.


Result: 89 patients with CMV hepatitis were followed for 6 months with the following rates: The average age of patients was 2.17 ± 1,596 months, and the ratio of males to females (2.5 : 1), jaundice 86.5%, hepatomegaly 64.0%, feces of silver color 52.8%, dark urine 44.9%, subcutaneous hemorrhage 4.5%. Most transaminases increase slightly and rarely exceed 400U/L. Direct billirubin increased by 91.2%. 66/89 are eligible for antiviral therapy with ganciclovir/ Valganciclovir. Improvement in liver damage was 90.9% and nocomplications accounted for 90.9%.


Conclusion: Most patients have good results after treatment. However, it is necessary to detect and treat in time to limit the severe damage caused by CMV.

##plugins.themes.vojs.article.details##

References

1. Bilavsky E, Schwarz M, Bar-Sever Z et al. Hepatic involvement in congenital cytomegalovirus infection - infrequent yet signifcant. J. Viral Hepat 2015;22(9):763-768. https://doi.org/10.1111/jvh.12374
2. Costa JM, PintoSM, Santos-Silva E et al. Incidental hypertransaminasemia in children-a stepwise approach in primary care. Eur. J. Pediatr 2023;182(4):1601-1609. https://doi.org/10.1007/s00431-023-04825-4
3. Khúc Văn Lập. Nghiên cứu lâm sàng, cận lâm sàng bệnh do Cytomegalovirus ở trẻ em tại Bệnh viện Nhi Trung ương. Luận văn tốt nghiệp thạc sỹ, Đại học Y Hà Nội, 2009.
4. Huỳnh Trọng Dân. Đặc điểm lâm sàng, cận lâm sàng và diễn tiến viêm gan do Cytomegalovirus từ 1-12 tháng tại bệnh viện Nhi Đồng 2. Tạp chí Y học TP.Hồ Chí Minh 2007;11(4).
5. Phạm Nhật An. Nguyễn Văn Lâm, Võ Mạnh Hùng, Nguyễn Phương Thảo. Một số đặc điểm dịch tế học lâm sàng của viêm gan cấp do Cytomegalovirus tại Bệnh viện Nhi Trung ương 2015 -2016. Tạp chí Nhi khoa 2015;8(5).
6. Kotton CN, Kumar D, Caliendo Am et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation 2018;102(6):900-931. https://doi.org/10.1097/tp.0000000000002191
7. Çelikel E, Tezer H, Kanik-Yuksek S et al. Evaluation of 98 immunocompetent children with cytomegalovirus infection: importance of neurodevelopmental follow-up. Eur J Pediatr 2015;174(8):1101-1107. https://doi.org/10.1007/s00431-015-2513-9
8. Rafailidis PI, Mourtzoukou EG, Varbobitis IC et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008;5(47). https://doi.org/10.1186/1743-422X-5-47
9. Oliver SE, Cloud GA, Saschez PJ et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J. Clin. Virol 2009;46 Suppl 4(Suppl 4):S22-S26. https://doi.org/10.1016/j.jcv.2009.08.012
10. Đỗ Văn Đô. Tổn thương gan cấp do nhiễm cytomegalovirus. Hướng dẫn chẩn đoán và điều trị bệnh trẻ em, Hà Nội, 2020:368-370.